Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation
- 1 March 1996
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 56 (3) , 181-183
- https://doi.org/10.1111/j.1600-0609.1996.tb01340.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma.Journal of Clinical Oncology, 1993
- Extramedullary progression of multiple myeloma following GM‐CSF treatment — grounds for caution?European Journal of Haematology, 1992
- High-risk multiple myeloma treated with high-dose melphalan.Journal of Clinical Oncology, 1992
- Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the diseaseBritish Journal of Haematology, 1991
- Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factor.The Journal of Immunology, 1988
- Anaplastic myeloma with massive extramedullar involvement: Report of two casesCancer, 1983
- Aggressive phase of multiple myeloma with pulmonary cell infiltratesPublished by American Medical Association (AMA) ,1982
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982